John A. Ward

Array ( [id] => 1073614 [patent_doc_number] => 06838279 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-04 [patent_title] => 'Herpes simplex virus type 1 (HSV-1)-derived vector for selectively inhibiting malignant cells and for expressing desired traits in malignant and non-malignant mammalian cells' [patent_app_type] => utility [patent_app_number] => 10/046491 [patent_app_country] => US [patent_app_date] => 2001-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8859 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838279.pdf [firstpage_image] =>[orig_patent_app_number] => 10046491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1077024 [patent_doc_number] => 07615537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Methods for treating blood coagulation disorders' [patent_app_type] => utility [patent_app_number] => 10/057620 [patent_app_country] => US [patent_app_date] => 2001-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 11066 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615537.pdf [firstpage_image] =>[orig_patent_app_number] => 10057620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6739701 [patent_doc_number] => 20030157070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations' [patent_app_type] => new [patent_app_number] => 10/001729 [patent_app_country] => US [patent_app_date] => 2001-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32832 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157070.pdf [firstpage_image] =>[orig_patent_app_number] => 10001729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 672636 [patent_doc_number] => 07091396 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-15 [patent_title] => 'Animals, cells and methods for production of detectably-labeled antibodies' [patent_app_type] => utility [patent_app_number] => 09/982120 [patent_app_country] => US [patent_app_date] => 2001-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7509 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/091/07091396.pdf [firstpage_image] =>[orig_patent_app_number] => 09982120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5968253 [patent_doc_number] => 20020090692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Novel polynucleotides and polypeptides encoded thereby' [patent_app_type] => new [patent_app_number] => 09/974294 [patent_app_country] => US [patent_app_date] => 2001-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60663 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20020090692.pdf [firstpage_image] =>[orig_patent_app_number] => 09974294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935406 [patent_doc_number] => 20020061289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Stem cell-based methods for preventing and treating tumor' [patent_app_type] => new [patent_app_number] => 09/969892 [patent_app_country] => US [patent_app_date] => 2001-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5426 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061289.pdf [firstpage_image] =>[orig_patent_app_number] => 09969892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6628907 [patent_doc_number] => 20020086421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Tumor cells with increased immunogenicity and uses therefor' [patent_app_type] => new [patent_app_number] => 09/966148 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14904 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086421.pdf [firstpage_image] =>[orig_patent_app_number] => 09966148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340664 [patent_doc_number] => 20020034503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Retrovirus-mediated gene transfer' [patent_app_type] => new [patent_app_number] => 09/964094 [patent_app_country] => US [patent_app_date] => 2001-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3928 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034503.pdf [firstpage_image] =>[orig_patent_app_number] => 09964094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5787305 [patent_doc_number] => 20020160502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Recombinant BCG vaccines for the prevention and treatment of cancer' [patent_app_type] => new [patent_app_number] => 09/965131 [patent_app_country] => US [patent_app_date] => 2001-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15530 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160502.pdf [firstpage_image] =>[orig_patent_app_number] => 09965131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 709601 [patent_doc_number] => 07056503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Enclosures housing cell-coated supports for treating tumors' [patent_app_type] => utility [patent_app_number] => 09/962059 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 24433 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056503.pdf [firstpage_image] =>[orig_patent_app_number] => 09962059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1123185 [patent_doc_number] => 06794188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-21 [patent_title] => 'Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof' [patent_app_type] => B2 [patent_app_number] => 09/961933 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 14408 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/794/06794188.pdf [firstpage_image] =>[orig_patent_app_number] => 09961933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6243102 [patent_doc_number] => 20020045594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Polynucleotide vaccine formulations' [patent_app_type] => new [patent_app_number] => 09/950844 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18150 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045594.pdf [firstpage_image] =>[orig_patent_app_number] => 09950844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6934245 [patent_doc_number] => 20010055589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-27 [patent_title] => 'Cancer immunotherapy improved by prior radiotherapy' [patent_app_type] => new [patent_app_number] => 09/931440 [patent_app_country] => US [patent_app_date] => 2001-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6700 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20010055589.pdf [firstpage_image] =>[orig_patent_app_number] => 09931440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1281589 [patent_doc_number] => 06642208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-04 [patent_title] => 'Enhancement of vascular function by modulation of endogenous nitric oxide production or activity' [patent_app_type] => B2 [patent_app_number] => 09/930833 [patent_app_country] => US [patent_app_date] => 2001-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13846 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642208.pdf [firstpage_image] =>[orig_patent_app_number] => 09930833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715435 [patent_doc_number] => 20030026783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Method of modulating neutralizing antibodies formation in mammals, and uses thereof in gene therapy, animal transgenesis and in functional inactivation of an endogenous proteins' [patent_app_type] => new [patent_app_number] => 09/920902 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12441 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20030026783.pdf [firstpage_image] =>[orig_patent_app_number] => 09920902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774196 [patent_doc_number] => 20030017534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Production of humanized antibodies in transgenic animals' [patent_app_type] => new [patent_app_number] => 09/921819 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16970 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017534.pdf [firstpage_image] =>[orig_patent_app_number] => 09921819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7065516 [patent_doc_number] => 20010044420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms' [patent_app_type] => new [patent_app_number] => 09/919145 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10451 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20010044420.pdf [firstpage_image] =>[orig_patent_app_number] => 09919145 [rel_patent_id] =>[rel_patent_doc_number] =>)